Education
About Us
Working with TipRanks
Follow Us
Mona Ashiya Insider Profile
4 Followers
Mona Ashiya, Director, Ten Percent Owner at Sierra Oncology, holds 235.39K shares in Disc Medicine (Ticker: IRON), holds 0.00 shares in Sierra Oncology (Ticker: SRRA). Most recently, Mona Ashiya Bought ― shares of Disc Medicine on Jun 20, 2024 for an estimated value of 3.00M.
Mona Ashiya Sierra Oncology (SRRA)Director, Ten Percent Owner
Sierra Oncology (SRRA)
Director, Ten Percent Owner
Ranked #6,573 out of 100,956 Corporate Insiders
Profitable Transactions
5 out of 5 Profitable Transactions
Average Return
+52.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Mona Ashiya holds in companies
Most Profitable Insider Trade
The most profitable trade made by Mona Ashiya
Mona Ashiya's Trading History
Sierra Oncology
Jul 01, 2022
―
Uninformative Sell
108.06M
$0.00
Disc Medicine
Jun 20, 2024
Director
Informative Buy
3.00M
$13.10M
List of latest transactions for each holding click on a transaction to see Mona Ashiya's performance on stock
You May Also Like
Mona Ashiya insider profile FAQ
What is the percentage of profitable transactions made by Mona Ashiya?
The percentage of profitable transactions made by Mona Ashiya is 100%.
What is the average return per transaction made by Mona Ashiya?
The average return per transaction made by Mona Ashiya is 52.90%.
What stocks does Mona Ashiya hold?
Mona Ashiya holds: SRRA, IRON stocks.
What was Mona Ashiya’s latest transaction?
Mona Ashiya latest transaction was an Informative Buy of $3.00M.
What was Mona Ashiya's most profitable transaction?
Mona Ashiya’s most profitable transaction was an Informative Buy of IRON stock on February 17, 2023. The return on the trade was 143.40%.
What is Mona Ashiya's role in Sierra Oncology?
Mona Ashiya's role in Sierra Oncology is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.